Zdrowie i gospodarka · 15.05.2025
Centers for Medicare & Medicaid Services Announces Public Comment Opportunity for Medicare Drug Price Negotiation Program Draft Guidance
The Centers for Medicare & Medicaid Services is seeking public comments on its draft guidance for the Medicare Drug Price Negotiation Program, which aims to renegotiate drug prices for 2026, 2027, and 2028 under the Inflation Reduction Act.